Abstract
During the 1970s there was a trend toward the use of tissue or heterograft valves in order to avoid the high rate of thromboembolism and anticoagulant related complications associated with mechanical prostheses. Use of bioprostheses appears to have reduced thromboembolic complications, but unfortunately, bioprosthesis must still be considered a temporary valve substitute. Due to its limited durability, one must consider the risks of future reoperation for valve replacement when weighing the potential benefits of a bioprosthesis. This chapter assesses the risks of valve reoperation and its effect on subsequent longevity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Pluth, J.R. (1985). Reoperation after Cardiac Valve Surgery: Elective, Urgent and Emergent. In: Matloff, J.M. (eds) Cardiac Valve Replacement. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2601-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2601-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9629-4
Online ISBN: 978-1-4613-2601-4
eBook Packages: Springer Book Archive